2211 — Universal Health International Holding Share Price
Last trade - 00:00- HK$70.49m
- HK$40.47m
- CNY1.09bn
- 10
- 100
- 28
- 42
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.2 | ||
| Price to Tang. Book | 0.2 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.07 | ||
| EV to EBITDA | 1.47 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.86% | ||
| Return on Equity | 4.03% | ||
| Operating Margin | 1.4% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 1,510.13 | 1,185.17 | 1,273.57 | 1,297.04 | 1,089.04 | n/a | n/a | -14.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Universal Health International Group Holding Ltd is a company principally engaged in the distributions and retails of drugs and other pharmaceutical products. The Company operates its businesses through three segments. Retail Business segment is mainly engaged in the retails of drugs and other pharmaceutical products. Distribution Business segment is mainly involved in the distributions of drugs and other pharmaceutical products. Others segment is mainly involved in investing companies. The Company’s products include prescribed drugs, non-prescribed drugs, healthcare products and other pharmaceutical products. The Company mainly operates its businesses in the domestic market.
Directors
- Dongtao Jin CHM (52)
- Chuanfu Chu CEO (51)
- Dongkun Jin VCH (42)
- Zehua Zhao GMG (46)
- Junming Ge SEC (49)
- Sheung Hing Cheng NID (67)
- Su Hui Chiang NID (68)
- Haiyan Zou NID (52)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 12th, 2012
- Public Since
- December 12th, 2013
- No. of Employees
- 1,198
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 801,059,558
- Address
- No. 14-1, SHENYANG
- Web
- https://www.uhighl.com/
- Phone
- Auditors
- Forvis Mazars
Upcoming Events for 2211
Similar to 2211
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:52 UTC, shares in Universal Health International Holding are trading at HK$0.09. This share price information is delayed by 15 minutes.
Shares in Universal Health International Holding last closed at HK$0.09 and the price had moved by +114.29% over the past 365 days. In terms of relative price strength the Universal Health International Holding share price has outperformed the FTSE Developed Asia Pacific Index by +116.73% over the past year.
There is no consensus recommendation for this security.
Find out moreUniversal Health International Holding does not currently pay a dividend.
Universal Health International Holding does not currently pay a dividend.
Universal Health International Holding does not currently pay a dividend.
To buy shares in Universal Health International Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.09, shares in Universal Health International Holding had a market capitalisation of HK$70.49m.
Here are the trading details for Universal Health International Holding:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2211
Based on an overall assessment of its quality, value and momentum Universal Health International Holding is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Universal Health International Holding. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -30.89%.
As of the last closing price of HK$0.09, shares in Universal Health International Holding were trading -20.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Universal Health International Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Universal Health International Holding's management team is headed by:
- Dongtao Jin - CHM
- Chuanfu Chu - CEO
- Dongkun Jin - VCH
- Zehua Zhao - GMG
- Junming Ge - SEC
- Sheung Hing Cheng - NID
- Su Hui Chiang - NID
- Haiyan Zou - NID